Extraction Method and Analysis of Cannabinoids in Cannabis Olive Oil Preparations

Abstract

Recently, an increasing number of pharmacists had to supply medicinal products based on Cannabis sativa L. (Cannabaceae), prescribed by physicians to individual patients. Cannabis olive oil preparation is the first choice as a concentrated extract of cannabinoids, even though standardized operative conditions for obtaining it are still not available. In this work, the impact of temperature and extraction time on the concentration of active principles was studied to harmonize the different compounding methods, optimize the extraction process, and reduce the variability among preparations. Moreover, starting from the cannabis inflorescence, the effect of temperature on tetrahydrocannabinolic acid decarboxylation was evaluated. For the analysis, a GC/MS method, as suggested by the Italian Ministry of Health, and a GC/flame ionization detection method were developed, validated, and compared.

Key words

Cannabis sativa - Cannabaceae - olive oil preparation - cannabinoids - extraction - GC/FID - GC/MS

• References

• 1 Russo E, Guy GW. A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Med Hypoth 2006; 66: 234-246
• 2 Navari RM. Management of chemotherapy-induced nausea and vomiting: focus on newer agents and new uses for older agents. Drugs 2013; 73: 249-262
• 3 Finnerup NB, Attal N, Haroutounian S, Mcnicol E, Baron R, Dworkin RH, Gilron I, Haanpää M, Hansson P, Jensen TS, Kamerman PR, Lund K, Moore A, Raja SN, Rice AS, Rowbotham M, Sena E, Siddall P, Smith BH, Wallace M. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 2015; 14: 162-173
• 4 Leussink VI, Husseini L, Warnke C, Broussalis E, Hartung HP, Kieseier BC. Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity. Ther Adv Neurol Disord 2012; 5: 255-266
• 5 Haney M, Gunderson EW, Rabkin J, Hart CL, Vosburg SK, Comer SD, Foltin RW. Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep. J Acquir Immune Defic Syndr 2007; 5: 545-554
• 6 Adams M. FDA approves liquid marijuana for AIDS and cancer patients. Available at. http://hightimes.com/news/fda-approves-liquid-marijuana-for-aids-and-cancer-patients/ Accessed July 28, 2016
• 7 Jayesh P. Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs. Res Soc Admin Pharm 2016; 12: 638-654
• 8 Akeroyd JR. Cannabis L. In: Tutin TG, Burges NA, Chater AO, Edmondson JR, Heywood VH, Moore DM, Valentine DH, Walters SM, Webb DA. eds. Flora Europaea, vol. 1. 2. ed.. Cambridge: Cambridge University Press; 1992: 78
• 9 Lercker G, Bocci F, Frega N, Bortolomeazzi R. Cannabinoid acids analysis. Farmaco 1992; 47: 367-378
• 10 Perrotin-Brunel H, Buijs W, van Spronsen J, van Roosmalenb MJE, Petersa CJ, Verpoorted R, Witkampa GJ. Decarboxylation of Δ9-tetrahydrocannabinol: Kinetics and molecular modelling. J Mol Struct 2011; 987: 67-73
• 11 Politi M, Peschel W, Wilson N, Zloh M, Prieto JM, Heinrich M. Direct NMR analysis of cannabis water extracts and tinctures and semi-quantitative data on Δ9-THC and Δ9-THC-acid. Phytochemistry 2008; 69: 562-570
• 12 Veress T, Szanto JI, Leisztner L. Determination of cannabinoid acids by high-performance liquid chromatography of their neutral derivatives formed by thermal decarboxylation: I. Study of the decarboxylation process in open reactors. J Chromatogr A 1990; 520: 339-347
• 13 Grotenhermen F. Harm reduction associated with inhalation and oral administration of cannabis and THC. J Cann Ther 2001; 1: 133-152
• 14 GW Pharma Company. GW pharmaceuticals, summary of product characteristics, 2011. Available at. https://www.gwpharm.com/products-pipeline/sativex/patient-information/summary-product-characteristics Accessed April 21, 2016
• 15 Hazekamp A, Bastola K, Rashidi H, Bender J, Verpoorte R. Cannabis tea revisited: a systematic evaluation of the cannabinoid composition of cannabis tea. J Ethnopharmacol 2007; 113: 85-90
• 16 Romano LL, Hazekamp A. Cannabis oil: chemical evaluation of an upcoming cannabis-based medicine. Cannabinoids 2013; 1: 1-11
• 17 Hazekamp A. An evaluation of the quality of medicinal grade cannabis in the Netherlands. Cannabinoids 2006; 1: 1-9
• 18 Analytical Monograph Cannabis Flos (flowers/granulated) OMC/Farmalyse BV, Version 7.1/November 28, 2014. Available at. https://www.cannabisbureau.nl/Media/Default/PDF/Monograph%20Cannabis%20Flos%20Version%207.1%20(November%2028,%202014).pdf Accessed November 28, 2014
• 19 Evert RF. Esauʼs Plant Anatomy: Meristems, Cells, and Tissues of the Plant Body: Their Structure, Function, and Development. 3rd ed.. ed. Hoboken, New Jersey: John Wiley & Sons; 2006
• 20 Mahlberg PG, Kim ES. Accumulation of cannabinoids in glandular trichomes of Cannabis (Cannabaceae). J Ind Hemp 2004; 9: 15-36
• 21 Dayanandan P, Kaufman PB. Trichomes of Cannabis sativa L. (Cannabaceae). Am J Bot 1976; 63: 578-591
• 22 Happyana N, Agnolet S, Muntendam R, Van Dam A, Schneider B, Kayser O. Analysis of cannabinoids in laser-microdissected trichomes of medicinal Cannabis sativa using LCMS and cryogenic NMR. Phytochemistry 2013; 87: 51-59
• 23 Izzo AA, Borrelli F, Capasso R, Di Marzo V, Mechoulam R. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci 2009; 30: 515-527